Interaction on metabolic clearance between A-type and B-type natriuretic peptides in patients with heart failure

Metabolism: Clinical and Experimental

Volumn 49, Issue 9, 2000, Pages 1228-1233

  Yoshimura, M ^a   Mizuno, Y ^a   Harada, E ^a   Nakayama, M ^a   Shimasaki, Y ^a   Ito, T ^a   Nakamura, S ^a   Soejima, H ^a   Miyamoto, S ^a   Takazoe, K ^a   Ogawa, H ^a   Kugiyama, K ^a   Saito, Y ^a   Nakao, K ^a   Yasue, H ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AORTA ROOT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY SINUS; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0033821925     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.8602     Document Type: Article

References (41)

1. Atrial natriuretic factor: A hormone produced by the heart
2. Structural identification of beta- and gamma-human atrial natriuretic polypeptides
3. A new natriuretic peptide in porcine brain
4. Atrial natriuretic hormone, the renin aldosterone axis, and blood pressure-electrolyte homeostasis
5. Atriopeptin: A cardiac hormone intimately involved in fluid, electrolyte, and blood pressure homeostasis
6. Sympathoinhibitory effects of atrial natriuretic factor in normal humans
7. Atrial natriuretic peptide elevation in congestive heart failure in the human
8. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure
9. Increased secretion of atrial natriuretic polypeptide (ANP) from the left ventricle in the patients with dilated cardiomyopathy
10. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart
11. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide
12. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
13. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure
14. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy
15. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction
16. Molecular biology and biochemistry of the natriuretic peptide system. II. Natriuretic peptide receptors
17. The pharmacokinetics of alpha-human atrial natriuretic polypeptide in healthy subjects
18. Altered tissue degradation and distribution of atrial natriuretic peptide in patients with idiopathic dilated cardiomyopathy and its relationship with clinical severity of the disease and sodium handling
19. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion
20. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function
21. ANF disappearance and tissue distribution in rats
22. Differing metabolism and bioactivity of atrial and brain natriuretic peptides in essential hypertension
23. Circulatory model in metabolic studies of rapidly renewed hormones: Application to ANP kinetics
24. Renal metabolism of atrial natriuretic peptide in the rat
25. 125I-atrial natriuretic factor in anesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade
26. Physiological role of silent receptor or atrial natriuretic factor
27. Atrial natriuretic clearance receptor: Complete sequence and functional expression of cDNA clones
28. Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA
29. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide
30. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11
31. Inhibition of ANP clearance receptors and endopeptidase 24.11 in maturing rats
32. Clearance receptors and endopeptidase: Equal role in natriuretic peptide metabolism in heart failure
33. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure
34. Localization of clearance receptor in rat lung and trachea: Association with chondrogenic differentiation
35. Fundamental and clinical evaluation of 'Shionoria ANP,' human atrial natriuretic peptide IRMA kit
36. Plasma levels of brain natriuretic peptide in normal subjects and patients with chronic congestive heart failure: Measurement by immunoradiometric assay (IRMA)
37. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure
38. Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide
39. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones
40. Isolation and sequence determination of human brain natriuretic peptide in human atrium
41. Biological characterization of human brain natriuretic peptide (BNP) and rat BNP: Species-specific actions of BNP